<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04663191</url>
  </required_header>
  <id_info>
    <org_study_id>T38</org_study_id>
    <nct_id>NCT04663191</nct_id>
  </id_info>
  <brief_title>Intraoperative Conversion During Video-assisted Thoracoscopy Resection for Lung Cancer Does Not Alter Survival</brief_title>
  <acronym>ICVATR</acronym>
  <official_title>Intraoperative Conversion During Video-assisted Thoracoscopy Resection for Lung Cancer Does Not Alter Survival</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire, Amiens</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire, Amiens</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Anatomical resection with systematic lymph-node dissection is currently the standard of care&#xD;
      for the treatment of early stage non-small cell lung cancer. The use of minimally invasive&#xD;
      approaches has increased greatly over the last two decades [either video-assisted&#xD;
      thoracoscopic surgery (VATS) or robotic-assisted thoracoscopic surgery (RATS)], as they&#xD;
      provide the patient with better outcomes than open thoracotomy. Minimally invasive VATS&#xD;
      lobectomy for a standard case is generally a straightforward procedure for a well-trained&#xD;
      surgical team, although concomitant preoperative pathologies or intraoperative&#xD;
      findings/adverse events may result in technical difficulties, leading to intraoperative&#xD;
      conversion, commonly by thoracotomy.&#xD;
&#xD;
      The investigators aimed to assess long-term outcomes in a consecutive cohort of patients&#xD;
      treated by anatomical pulmonary resection either using VATS, VATS requiring intraoperative&#xD;
      conversion to thoracotomy, or upfront open thoracotomy for lung-cancer surgery.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 2, 2020</start_date>
  <completion_date type="Actual">December 3, 2020</completion_date>
  <primary_completion_date type="Actual">December 2, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Overall survival during the follow-up period after surgery</measure>
    <time_frame>from day of surgery up to 7 years</time_frame>
  </primary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Actual">843</enrollment>
  <condition>Video-assisted Thoracoscopic Surgery</condition>
  <condition>Lung Cancer</condition>
  <condition>Lobectomy</condition>
  <condition>Survival</condition>
  <condition>Surgery</condition>
  <arm_group>
    <arm_group_label>Full VATS</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>VATS with conversion</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Thoracotomy upfront</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>anatomical resection</intervention_name>
    <description>Anatomical resection with systematic lymph-node dissection</description>
    <arm_group_label>Full VATS</arm_group_label>
    <arm_group_label>Thoracotomy upfront</arm_group_label>
    <arm_group_label>VATS with conversion</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All consecutive patients treated by anatomical lobar pulmonary resection (lobectomy,&#xD;
        bilobectomy) or anatomical sublobar pulmonary resection (segmentectomy) for non-small cell&#xD;
        lung cancer (NSCLC), either by VATS (eventually with intraoperative conversion) or upfront&#xD;
        thoracotomy.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  All consecutive patients treated by anatomical lobar pulmonary resection (lobectomy,&#xD;
             bilobectomy) or anatomical sublobar pulmonary resection (segmentectomy) for non-small&#xD;
             cell lung cancer (NSCLC), either by VATS (eventually with intraoperative conversion)&#xD;
             or upfront thoracotomy.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  patients with non-anatomical pulmonary resection (wedge resection)&#xD;
&#xD;
          -  patients with a histology other than NSCLC (benign or metastatic from another&#xD;
             primitive cancer), stage IV NSCLC disease,&#xD;
&#xD;
          -  patients with multiple primary NSCLC (synchronous or metachronous)&#xD;
&#xD;
          -  patients with incomplete resection (R+)&#xD;
&#xD;
          -  patient for whom a VATS approach was never considered&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>CHU Amiens</name>
      <address>
        <city>Amiens</city>
        <zip>80480</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>December 4, 2020</study_first_submitted>
  <study_first_submitted_qc>December 4, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 10, 2020</study_first_posted>
  <last_update_submitted>December 11, 2020</last_update_submitted>
  <last_update_submitted_qc>December 11, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">December 16, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>video-assisted thoracoscopic surgery</keyword>
  <keyword>lung-cancer surgery</keyword>
  <keyword>intraoperative conversion to open surgery</keyword>
  <keyword>lobectomy</keyword>
  <keyword>survival</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

